SecBot SecBot
3 ·Filed Jul 13, 2026

BJDX

Bluejay Diagnostics, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed3mo ago SEC0001475597-26-000157
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

Monitor for any subsequent Schedule 13D filing if HRT shifts to activist stance. Given BJDX's tiny market cap and low liquidity, the entry of a large quantitative holder could amplify volatility. No immediate trade trigger.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
BJDX ▼ -19.08% at T+20d
NEUTRAL call -19.08% · α vs SPY -22.27% · entry $1.22 → $0.9872
Next anchor: T+60d due 21d ago
Entry = T+0 close
Jul 13, 2026
via day close
T+1d
+2.46%
call +2.46% · α +2.10%
$1.25
settled 4mo ago
T+5d
+18.85%
call +18.85% · α +19.64%
$1.45
settled 3mo ago
T+20d
-19.08%
call -19.08% · α -22.27%
$0.9872
settled 3mo ago
T+60d
Pending
due 21d ago

Price Chart

Loading chart...

Executive Summary

HRT Financial LP, a quantitative trading firm, filed a Form 3 disclosing beneficial ownership of 126,993 shares of Bluejay Diagnostics (BJDX), indicating it has crossed the 10% ownership threshold in this micro-cap diagnostics stock. This signals a significant new institutional holder, though no activist intent is stated. The filing is a routine disclosure with no immediate fundamental catalyst.

Key Facts

  • HRT Financial LP reported beneficial ownership of 126,993 shares of BJDX common stock as of July 9, 2026.
  • The filing indicates HRT holds more than 10% of BJDX's outstanding shares, given the $2M market cap.
  • HRT is a large quantitative trading firm, not typically an activist investor.
  • The filing was made on July 13, 2026, within the required timeframe.

Financial Impact

No direct financial impact; ownership disclosure only.

ownership concentration

Risk Factors

  • HRT may reduce or exit the position, causing downward pressure on the thinly traded stock.
  • Low liquidity and weak analyst consensus (0% bullish) add downside risk.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001475597-26-000157
Document: 0001475597-26-000157-index.html0001475597-26-000157
Document: 0001475597-26-000157.txt0001475597-26-000157
18 reports for BJDX
Performance horizon
75% Hit rate @ T+20 6 of 8 directional calls Went positive at some point 6 of 8 best @ T+20▲ +159.65%May 18, 2026
Filters
Rows
Reports for BJDX — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
8-K
NEUTRAL ★ 3/10
$0.8323awaiting T+20—$0.5600 (−32.72%)
Oct 6, 2026
20d ago
8-K
NEUTRAL ★ 4/10
$0.8107awaiting T+20—$0.5600 (−30.92%)
Aug 13, 2026
10w ago
8-K
NEUTRAL ★ 4/10
$1.06awaiting T+20—$0.5600 (−47.17%)
Aug 13, 2026
10w ago
Press Release
NEUTRAL ★ 4/10
$1.06awaiting T+20—$0.5600 (−47.17%)
Jul 22, 2026
13w ago
8-K
BULLISH ★ 5/10
$1.14 $0.9393▼ −17.61%▼ −20.91%$0.5600 (−50.88%)
Jul 13, 2026
15w ago
3
NEUTRAL ★ 4/10
$1.22 $0.9872▼ −19.08%▼ −22.27%$0.5600 (−54.10%)
Jul 10, 2026
15w ago
3
NEUTRAL ★ 2/10
$1.45 $1.07▼ −26.21%▼ −28.63%$0.5600 (−61.38%)
Jun 29, 2026
17w ago
EFFECT
BEARISH ★ 7/10
$1.44 $1.03▲ +28.47%▲ +28.19%$0.5600 (+61.11%)
Jun 17, 2026
18w ago
S-3
BEARISH ★ 7/10
$4.46 $1.30▲ +70.85%▲ +71.39%$0.5600 (+87.44%)
Jun 9, 2026
19w ago
8-K
NEUTRAL ★ 4/10
$4.49 $1.40▼ −68.82%▼ −72.44%$0.5600 (−87.53%)
Showing 10 of 18

US Market Status

Market Closed — Opens in 1h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 13, 2026